Youcare / Actavis Corona CA

Acquisition of Actavis’s 285,433 SF oral solid dosage manufacturing facility and 196,613 SF packaging facility in Corona, CA by Youcare Pharmaceutical Group

The Challenge

Youcare Pharmaceutical Group, a significant generic pharmaceutical manufacturer based in China, engaged PharmaBioSource Realty to acquire two facilities from Actavis. Youcare sought to establish its first presence in the U.S. in order to gain access to the FDA-regulated generic pharmaceutical market.

The Solution

PharmaBioSource Realty provided real estate services to support Youcare’s acquisition of the Corona, California facilities.

Services provided by the PharmaBioSource Realty team:

  • Facility identification and evaluation
  • Real estate and due diligence services in support of the acquisition

The Results

Youcare acquired Actavis’s 285,433-square-foot oral solid dosage facility — fully equipped to manufacture over two billion tablets and capsules annually — and the 196,613-square-foot packaging facility, which housed four bottle filling lines and one blister packaging line, to establish its first U.S. presence.

What We Did

Buy-Side Advisory

Facility Acquisition